| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 02/04/2010 | WO2010012619A1 Diazepan and piperazine derivatives modulators of chemokine receptors |
| 02/04/2010 | US20100029689 Phosphodiesterase 4 inhibitors |
| 02/04/2010 | US20100029686 Hcv protease inhibitors and uses thereof |
| 02/04/2010 | US20100029678 Diuretics |
| 02/04/2010 | US20100029670 Organic compounds |
| 02/04/2010 | US20100029658 Heterocyclic derivatives, pharmaceutical compositions and methods of use thereof |
| 02/04/2010 | US20100029623 4-(1-amino-ethyl)-cyclohexylamine derivatives |
| 02/04/2010 | US20100029621 Hexafluoroisopropanol derivatives |
| 02/04/2010 | US20100029598 Extended Benzamide Derivatives as Modulators of the EP2 Receptor |
| 02/04/2010 | US20100028257 Pharmaceutical compounds |
| 02/04/2010 | CA2730770A1 Diazepan and piperazine derivatives modulators of chemokine receptors |
| 02/03/2010 | EP1511742B1 Kinase inhibitors |
| 02/03/2010 | CN100586963C Alkoxyamines containing a radical polymerization group |
| 02/03/2010 | CN100586937C Ligustrazine stilbenoids derivatives, preparation method thereof, medicament composition and use |
| 02/02/2010 | US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 02/02/2010 | US7655666 Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655660 Antitumor antibiotic; water solubility, stability; N-[2-{(1-chloromethyl)-1,2-dihydro-5-[(4-methylpiperazino)carbonyloxy]-3H-benz(e)indol-3-yl}carbonyl]-1H-indol-5-yl]-5-[(3-methyldithio-1-oxopropyl)-amino]-1H-indole-2-carboxamide |
| 02/02/2010 | US7655658 Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds |
| 02/02/2010 | US7655653 Tetrahydrobenzfluorene derivatives |
| 01/28/2010 | WO2010011570A1 Adamantyl diamide derivatives and uses of same |
| 01/28/2010 | WO2010010909A1 Therapeutic agent for chronic renal failure |
| 01/28/2010 | WO2009132452A8 Diaryl-cyclylalkyl derivatives as calcium channel blockers |
| 01/28/2010 | WO2009124962A3 Sulfonamides |
| 01/28/2010 | WO2009123714A3 Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| 01/28/2010 | US20100022773 Apoptosis promoters |
| 01/28/2010 | US20100022547 Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections |
| 01/28/2010 | US20100022539 Isoxazole Compounds as Histamine H3 modulators |
| 01/28/2010 | US20100021922 Dark quenchers for donor-acceptor energy transfer |
| 01/28/2010 | US20100021382 Pyrazine Derivatives and Uses Thereof |
| 01/28/2010 | CA2728629A1 Adamantyl diamide derivatives and uses of same |
| 01/27/2010 | EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
| 01/26/2010 | US7652036 Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors |
| 01/26/2010 | US7652021 (2S)-4,4-difluoro-1-{N-[3-(pyrimidin-2-ylamino)-1-adamantyl]glycyl}pyrrolidine-2-carbonitrile; dipeptidyl peptidase IV enzyme inhibitors; non-insulin dependent diabetes mellitus |
| 01/26/2010 | US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 01/26/2010 | US7652014 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
| 01/26/2010 | CA2469380C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/26/2010 | CA2430579C Isoindolin-1-one glucokinase activators |
| 01/26/2010 | CA2338854C Nitric esters and nitrate salts of specific drugs |
| 01/21/2010 | WO2010009215A1 Nicotinic acid receptor agonist compounds useful to treat metabolic syndromes |
| 01/21/2010 | WO2010007248A2 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 01/21/2010 | WO2010007179A1 Heterocyclic derivatives that are used in the treatment of neurodegenerative diseases |
| 01/21/2010 | WO2010006938A1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
| 01/21/2010 | US20100016589 Novel Anthranilic Acid Derivative as Potential Anticancer Agent and a Process for the Preparation Thereof |
| 01/21/2010 | US20100016295 Preparation and Use of Biphenyl Amino Acid Derivatives for the Treatment of Obesity |
| 01/21/2010 | CA2730516A1 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 01/21/2010 | CA2730331A1 Heterocyclic derivatives that are used in the treatment of neurodegenerative diseases |
| 01/21/2010 | CA2730056A1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
| 01/20/2010 | EP2145879A1 Pyrazine derivatives, methods of use, and methods for preparing same |
| 01/20/2010 | EP2145012A2 Microbial reduction of an acetoxyketone |
| 01/20/2010 | EP2144890A1 Method for preparing halogenated amines |
| 01/20/2010 | EP1805141B1 Piperidines and related compounds for treatment of alzheimer's disease |
| 01/20/2010 | CN100582091C Bis-aryl sulfonamides |
| 01/19/2010 | US7649092 Urea derivatives as calcium channel blockers |
| 01/19/2010 | US7649011 Inhibitors of human tumor-expressed CCXCKR2 |
| 01/19/2010 | US7648991 Schizophrenia, psychoses, drug abuse, drug dependence, alcoholism; anxiolytic and antidepressant agents; psychological and bipolar disorders; crystallization, methylation, precipitation, separation |
| 01/19/2010 | US7648960 Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/14/2010 | WO2009132453A8 Cyclylamine derivatives as calcium channel blockers |
| 01/14/2010 | US20100010223 Pyrazine derivatives, Methods of use, and methods for preparing same |
| 01/14/2010 | US20100010222 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient |
| 01/14/2010 | US20100010012 Glutamate aggrecanase inhibitors |
| 01/14/2010 | US20100010011 Compounds that act as a vehicle for delivery through the blood-brain barrier and charge delivery vehicle constructions |
| 01/14/2010 | US20100010010 Hdac inhibitors |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100010000 Amino alcohol derivative and immunosuppresive agent having same as an active ingredient |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/13/2010 | EP2143716A1 Pyrazine derivatives, methods of use, and methods for preparing same |
| 01/13/2010 | EP2142519A1 Dpp-iv inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating a diabetes or an obesity |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN101624378A Pyrazine derivates, using method and preparing method |
| 01/13/2010 | CN100579969C Quinoxaline acquired by heavy ion beam irradiation effect |
| 01/13/2010 | CN100579957C Novel arylamidine derivative or salt thereof |
| 01/12/2010 | US7645764 Kinase inhibitors and methods for using the same |
| 01/12/2010 | US7645760 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 01/12/2010 | US7645758 (4-Methyl-piperazin-1-yl)-(6H-thieno[2,3-b]pyrrol-5-yl)-methanone; (2,3-Dichloro-6H-thieno[2,3-b]pyrrol-5-yl)-(4-methyl-piperazin-1-yl)-methanone; histamine H4 receptor antagonist; treats allergic rhinitis |
| 01/12/2010 | CA2511242C Inhibitors of human tumor-expressed ccxckr2 |
| 01/11/2010 | CA2641297A1 Pyrazine derivatives, methods of use, and methods for preparing same |
| 01/07/2010 | WO2009115517A3 Pyridines and pyrazines as inhibitors of pi3k |
| 01/07/2010 | WO2009050734A3 An industrially feasible process for the manufacture of bisquinoline derivatives by using substantially pure n-monosubstituted piperazines |
| 01/07/2010 | US20100004266 Salt or Solvate of 5-Methyl-2(Piperazin-1-Yl)Benzenesulfonic Acid |
| 01/07/2010 | US20100004255 Method of treating arrhythmias |
| 01/07/2010 | US20100004249 Bicyclic heterocyclic compound and use thereof |
| 01/06/2010 | EP2141153A2 Stereoselective alkylation of chiral 2-methyl-4 protected piperazines |
| 01/06/2010 | EP2141143A2 Stereoselective alkylation of chiral 2-methyl-4 protected piperazines |
| 01/06/2010 | EP1513831B1 Novel compounds, their use and preparation |
| 01/06/2010 | EP1005361B1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ENDOTHELIAL DYSFUNKTION AND FOR THE INHIBITION OF ANGIOGENESIS RESPECTIVELY |
| 01/06/2010 | CN100577163C Compounds effecting glucokinase |
| 01/05/2010 | US7642260 N-acylsulfonamide derivatives; BCL-X1 protein inhibitors; anticarcinogenic agents; bladder cancer; for example, N-(4-(4-((4'-chloro(1,1'-biphenyl)-2-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(dimethylamino)-1-((phenylsulfanyl)methyl)-propyl)amino)-3-nitrobenzenesulfonamide |
| 01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 12/31/2009 | US20090325972 Novel cinnamaldehyde derivatives having improved solubility in water, a method for preparing the same and a pharmaceutical composition comprising the same |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090324724 Soluble amide & ester pyrazinoylguanidine sodium channel blockers |
| 12/31/2009 | US20090324540 Compounds and compositions for delivering active agents |
| 12/30/2009 | WO2009157398A1 Therapeutic agent for inflammatory bowel disease |
| 12/30/2009 | WO2009157397A1 Therapeutic agent for intestinal tract injury accompanying administration of a non-steroid anti-inflammatory agent |
| 12/30/2009 | WO2009157396A1 Therapeutic agent for spinal canal stenosis |
| 12/30/2009 | WO2009156857A1 Substituted n-oxide pyrazine derivatives |